Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 260

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 260
---
 | ​ | None                 | ​ | ​ | None                     | ​ |
| 5              | ​ | ​ | Authorized Share Proposal    | ​ | ​ | FOR votes from a majority of the votes cast by the holders of shares present at the meeting (by virtual attendance) or represented by proxy and voting on the matter | ​ | ​ | None                 | ​ | ​ | None                     | ​ |
| 6              | ​ | ​ | Compensation Proposal        | ​ | ​ | FOR votes from a majority of shares present in person (by virtual attendance) or represented by proxy at the meeting and entitled to vote on the matter              | ​ | ​ | Against              | ​ | ​ | None                     | ​ |
| 7              | ​ | ​ | Adjournment Proposal         | ​ | ​ | FOR votes from a majority of shares present in person (by virtual attendance) or represented by proxy at the meeting and entitled to vote on the matter              | ​ | ​ | Against              | ​ | ​ | None                     | ​ |

The information in the preceding table with respect to the effect of broker non-votes may be incorrect or change before the special meeting. Therefore, if you are a beneficial owner and want to ensure that shares you beneficially own are voted in favor or against any or all of the Cara Proposals, the only way you can do so is to give your broker or nominee specific instructions as to how the shares are to be voted. If on the date of the Cara special meeting, or a date preceding the date on which the Cara special meeting is scheduled, Cara reasonably believes that (i) it will not receive proxies sufficient to obtain the required vote to approve the Stock Issuance Proposal, the Reverse Stock Split Proposal and/or the Authorized Share Proposal, whether or not a quorum would be present or (ii) it will not have sufficient shares of Cara common stock represented (whether in person or by proxy) to constitute a quorum necessary to conduct the business of the Cara special meeting, Cara may postpone or adjourn, or make one or more successive postponements or adjournments of, the Cara special meeting as long as the date of the Cara special meeting is not postponed or adjourned more than an aggregate of 30 calendar days in connection with any postponements or adjournments. No Cara Proposal is contingent upon any other Cara Proposal. However, each of the Stock Issuance Proposal, the Reverse Stock Split Proposal and the Authorized Share Proposal is a condition to the consummation of